Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
Latest action · Sep 18, 2020 Referred to the House Committee on Energy and Commerce.
Progress
Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried. A simple resolution is the business of one chamber alone: it is not sent to the other chamber or to the President, and does not become law.
- IntroducedSep 18, 2020
- Agreed to in HouseNot reached
Summary
This resolution expresses the sense of the House of Representatives that federal agencies should take appropriate actions to (1) ensure meaningful engagement of communities of color in the conduct of COVID-19 (i.e., coronavirus disease 2019) research and participation in clinical trials, and (2) improve equitable access to safe and effective vaccines.
Cosponsors 22
Members who signed on, in the order they did. Signatures ran from Sep 18, 2020 to Sep 30, 2020; 19 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Adriano Espaillat | Original | Sep 18, 2020 |
| D-NJ | Albio Sires | Original | Sep 18, 2020 |
| D-CA | Ami Bera | Original | Sep 18, 2020 |
| D-CA | Barbara Lee | Original | Sep 18, 2020 |
| D-NC | David E. Price | Original | Sep 18, 2020 |
| D-MD | David J. Trone | Original | Sep 18, 2020 |
| D-NJ | Donald M. Payne, Jr. | Original | Sep 18, 2020 |
| D-TX | Eddie Bernice Johnson | Original | Sep 18, 2020 |
| D-DC | Eleanor Holmes Norton | Original | Sep 18, 2020 |
| D-CA | Gilbert Ray Cisneros, Jr. | Original | Sep 18, 2020 |
| D-NY | Gregory W. Meeks | Original | Sep 18, 2020 |
| D-CT | Jahana Hayes | Original | Sep 18, 2020 |
| D-MA | James P. McGovern | Original | Sep 18, 2020 |
| D-NY | Jerrold Nadler | Original | Sep 18, 2020 |
| D-GU | Michael F. Q. San Nicolas | Original | Sep 18, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Sep 18, 2020 |
Actions 2
Everything that happened, newest first.
- Sep 18, 2020Introduced in House
- Sep 18, 2020Referred to the House Committee on Energy and Commerce.
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Cardiovascular and respiratory health
- Community life and organization
- Emergency medical services and trauma care
- Health
- Health care coverage and access
- Health programs administration and funding
- Immunology and vaccination
- Infectious and parasitic diseases
- Medical research
- Medical tests and diagnostic methods
- Minority health
- Research administration and funding
Text 1
Each version as it was printed, newest first.
- Sep 18, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
